Mosseri Marlio Charles bought NVCT
June 30, 2026 · Form 4 insider transaction
Mosseri Marlio Charles bought 50,000 shares of Nuvectis Pharma, Inc. at $18.32 per share, a transaction worth $916.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
Reflects the weighted average purchase price. The range of prices for the shares purchased was $18.29 to $18.32. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.; Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL SPF.